Consistent with data in the literature13,42, prolonged treatment with AXL inhibitors led to the partial restoration of epithelial morphology in mesenchymal breast cancer cells (not shown), repression of ZEB1 and reactivation of E-cadherin expression (Fig. 4b). This evidence concerns the gene ZEB1 and breast carcinoma.